Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.35
+0.18 (2.92%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Lifecore Biomedical Income Statement

Millions USD. Fiscal year is Jun - May.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Feb '25 May '24 May '23 May '22 May '21 May '20 2015 - 2019
Revenue
130.31128.26103.27111.27100.87160.07
Upgrade
Revenue Growth (YoY)
7.23%24.20%-7.19%10.31%-36.98%-71.29%
Upgrade
Cost of Revenue
86.7286.4175.2872.261.94123.68
Upgrade
Gross Profit
43.5941.8527.9939.0738.9436.39
Upgrade
Selling, General & Admin
47.2940.4638.9734.6629.3238.17
Upgrade
Research & Development
8.328.588.747.846.687.58
Upgrade
Operating Expenses
55.6149.0447.7142.536.0145.75
Upgrade
Operating Income
-12.02-7.19-19.72-3.432.93-9.37
Upgrade
Interest Expense
-22.1-18.09-17.58-15.47-8.93-4.65
Upgrade
Interest & Investment Income
----0.050.07
Upgrade
Other Non Operating Income (Expenses)
-2.1836.45-0.816.57-10.97-0.2
Upgrade
EBT Excluding Unusual Items
-36.311.17-38.11-12.33-16.92-14.14
Upgrade
Merger & Restructuring Charges
-1.51-1.66-4.18-8.36-13.36-4.05
Upgrade
Impairment of Goodwill
------7.9
Upgrade
Gain (Loss) on Sale of Assets
-6.89-2.11---
Upgrade
Asset Writedown
------6.35
Upgrade
Other Unusual Items
---23.74--1.11-1.2
Upgrade
Pretax Income
-44.79.51-63.93-20.69-29.79-30.65
Upgrade
Income Tax Expense
-0.050.180.31-5.21-6.35-8.77
Upgrade
Earnings From Continuing Operations
-44.669.33-64.24-15.48-23.44-21.87
Upgrade
Earnings From Discontinued Operations
02.68-35.33-101.24-8.86-16.32
Upgrade
Net Income to Company
-44.6512.01-99.56-116.72-32.29-38.19
Upgrade
Net Income
-44.6512.01-99.56-116.72-32.29-38.19
Upgrade
Net Income to Common
-49.412.01-99.56-116.72-32.29-38.19
Upgrade
Shares Outstanding (Basic)
333030292929
Upgrade
Shares Outstanding (Diluted)
333730292929
Upgrade
Shares Change (YoY)
9.14%22.36%1.67%0.59%0.45%1.94%
Upgrade
EPS (Basic)
-1.490.39-3.32-3.96-1.10-1.31
Upgrade
EPS (Diluted)
-1.490.32-3.32-3.97-1.10-1.31
Upgrade
Free Cash Flow
-10.87-18.14-38.92-52.53-8.75-43.73
Upgrade
Free Cash Flow Per Share
-0.33-0.49-1.30-1.78-0.30-1.50
Upgrade
Gross Margin
33.45%32.63%27.10%35.11%38.60%22.73%
Upgrade
Operating Margin
-9.22%-5.60%-19.10%-3.08%2.91%-5.85%
Upgrade
Profit Margin
-37.91%9.37%-96.41%-104.89%-32.01%-23.86%
Upgrade
Free Cash Flow Margin
-8.34%-14.14%-37.69%-47.21%-8.68%-27.32%
Upgrade
EBITDA
-3.491.17-7.0414.238.13-1.27
Upgrade
EBITDA Margin
-2.68%0.91%-6.82%12.79%8.06%-0.79%
Upgrade
D&A For EBITDA
8.538.3612.6817.665.28.1
Upgrade
EBIT
-12.02-7.19-19.72-3.432.93-9.37
Upgrade
EBIT Margin
-9.22%-5.60%-19.10%-3.08%2.91%-5.85%
Upgrade
Effective Tax Rate
-1.92%----
Upgrade
Revenue as Reported
130.31128.26103.27111.27--
Upgrade
Advertising Expenses
--0.010.0100.1
Upgrade
Updated Jan 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q